Jingxuan Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jingxuan Xu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Baojun Chen
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Laboratory Animal, Peking University Cancer Hospital and Institute, Beijing, China
14 shared publications - Chang Zhang
Peking University Shougang Hospital 6 Department of Pathology Beijing, China
14 shared publications - Dengbo Ji
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Surgery III, Peking University Cancer Hospital & Institute, Beijing, China
14 shared publications - Guifang Jia
Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China
14 shared publications - Haopeng Hong
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Surgery III, Peking University Cancer Hospital and Institute, Beijing, China
14 shared publications - Jin Gu
Department of Gastrointestinal Surgery, Peking University Shougang Hospital, Beijing, China
14 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
Validation that AKT3 overexpression enhances the invasion and migration capabilities of colorectal cancer cells.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 6 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
Validation that AKT3 overexpression enhances the invasion and migration capabilities of colorectal cancer cells.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Data from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
Colorectal ovarian metastasis (CROM), a distinct metastatic subtype of colorectal cancer, is associated with early disease onset and aggressive progression. CROM lacks specific treatment options, highlighting the need to elucidate the underlying biological mechanisms and potential therapeutic vulnerabilities. In this study, we performed integrated analyses of single-cell RNA sequencing (scRNA-seq) datasets from 155,163 cells across 35 patients from the in-house cohort and public datasets, with matched bulk transcriptomic profiling. The analysis identified AKT3+ epithelial–mesenchymal transition (EMT)-like cells at the invasive tumor–stroma interface as metastasis-initiating cells. Functional validation using in vivo xenograft models demonstrated that AKT3 deficiency reduced ovarian colonization, whereas AKT3 overexpression conferred a mesenchymal phenotype with invasive capacity. Furthermore, reciprocal cross-talk between AKT3+ mesenchymal-like cells and cancer-associated fibroblasts (CAF) played a key role in remodeling the tumor microenvironment. Multiplex immunofluorescence staining of primary tumor specimens revealed spatially coordinated AKT3+/SNAIL+/ITGB1+ tumor buds adjacent to αSMA+ CAFs at the invasive front. Critically, AKT3 inhibition or knockdown in patient-derived CROM organoids (CROM-PDO) significantly suppressed malignant phenotypes, recapitulating the AKT3 dependency. Collectively, these findings elucidate an AKT3-driven feedforward loop coupling EMT plasticity with CAF activation as a critical driver of CROM and propose CROM-PDOs as a robust platform for developing precision therapies targeting this aggressive colorectal cancer subtype.Significance:Single-cell analyses reveal AKT3-expressing mesenchymal-like cells as drivers of colorectal ovarian metastases, which depends on the dynamic cross-talk between cancer cells and cancer-associated fibroblasts within the immunosuppressive ovarian niche.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
Colorectal ovarian metastasis (CROM), a distinct metastatic subtype of colorectal cancer, is associated with early disease onset and aggressive progression. CROM lacks specific treatment options, highlighting the need to elucidate the underlying biological mechanisms and potential therapeutic vulnerabilities. In this study, we performed integrated analyses of single-cell RNA sequencing (scRNA-seq) datasets from 155,163 cells across 35 patients from the in-house cohort and public datasets, with matched bulk transcriptomic profiling. The analysis identified AKT3+ epithelial–mesenchymal transition (EMT)-like cells at the invasive tumor–stroma interface as metastasis-initiating cells. Functional validation using in vivo xenograft models demonstrated that AKT3 deficiency reduced ovarian colonization, whereas AKT3 overexpression conferred a mesenchymal phenotype with invasive capacity. Furthermore, reciprocal cross-talk between AKT3+ mesenchymal-like cells and cancer-associated fibroblasts (CAF) played a key role in remodeling the tumor microenvironment. Multiplex immunofluorescence staining of primary tumor specimens revealed spatially coordinated AKT3+/SNAIL+/ITGB1+ tumor buds adjacent to αSMA+ CAFs at the invasive front. Critically, AKT3 inhibition or knockdown in patient-derived CROM organoids (CROM-PDO) significantly suppressed malignant phenotypes, recapitulating the AKT3 dependency. Collectively, these findings elucidate an AKT3-driven feedforward loop coupling EMT plasticity with CAF activation as a critical driver of CROM and propose CROM-PDOs as a robust platform for developing precision therapies targeting this aggressive colorectal cancer subtype.Significance:Single-cell analyses reveal AKT3-expressing mesenchymal-like cells as drivers of colorectal ovarian metastases, which depends on the dynamic cross-talk between cancer cells and cancer-associated fibroblasts within the immunosuppressive ovarian niche.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
ScRNA-seq quality control metrics and cell type distribution in colorectal ovarian metastasis (CROM) samples.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
ScRNA-seq quality control metrics and cell type distribution in colorectal ovarian metastasis (CROM) samples.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
The inhibitory effect of the AKT inhibitor Uprosertib on the proliferation and migration of CRC cell lines (HT29 and SW480).
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
The inhibitory effect of the AKT inhibitor Uprosertib on the proliferation and migration of CRC cell lines (HT29 and SW480).
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
Pathway enrichment analysis and validation of AKT3, SNAIL, and CDH2 expression in CROM patient samples and organoids.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
Pathway enrichment analysis and validation of AKT3, SNAIL, and CDH2 expression in CROM patient samples and organoids.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 8 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
In vivo assessment of ovarian metastasis rates and tumor burden in mice following AKT3 knockdown or overexpression.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 8 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
In vivo assessment of ovarian metastasis rates and tumor burden in mice following AKT3 knockdown or overexpression.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 9 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
The effect of Uprosertib treatment and AKT3 knockdown on the viability and growth of patient-derived organoids (PDOs).
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 9 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
The effect of Uprosertib treatment and AKT3 knockdown on the viability and growth of patient-derived organoids (PDOs).
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
The effect of AKT3 knockdown on the proliferation, migration, invasion, and cytoskeletal structure of CRC cell lines.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
The effect of AKT3 knockdown on the proliferation, migration, invasion, and cytoskeletal structure of CRC cell lines.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 10 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
Identification of CAF subsets and analysis of ligand-receptor interactions between CAFs and epithelial cells.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 10 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
Identification of CAF subsets and analysis of ligand-receptor interactions between CAFs and epithelial cells.